3/3/2025 | 32 | REDACTED VERSION of 27 Reply to Response to Motion by Regeneron Pharmaceuticals, Inc.. (Vavala, Donald) (Entered: 03/03/2025) |
2/25/2025 | 31 | Letter to The Honorable Maryellen Noreika from Brian P. Egan regarding Amgen's response to Regeneron's February 25, 2025 letter (D.I. 30) - re 30 Letter,,. (Attachments: # 1 Exhibit A)(Egan, Brian) (Entered: 02/25/2025) |
2/25/2025 | 30 | Letter to The Honorable Maryellen Noreika from David E. Wilks regarding requests that the Court accept Applicant Regeneron Pharmaceuticals, Inc.'s Memorandum of Law in Response to Amgen Inc.'s Opposition to Regeneron's Ex Parte Application for an Order pursuant to 28 U.S.C. Section 1782 to take Discovery for use in Foreign Proceeding as filed and grant its Ex Parte Application - re 27 Reply to Response to Motion, 1 MOTION for Issuance of Letters Rogatory. (Wilks, David) (Entered: 02/25/2025) |
2/24/2025 | 29 | DECLARATION of Daryl Ong Hock Chye in Support of Memorandum of Law in Response to Amgen Inc.'s Opposition to Regeneron's Ex Parte Application for an Order pursuant to 28 U.S. C Section 1782 to take Discovery for use in Foreign Proceedings re 27 Reply to Response to Motion by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1-3)(Vavala, Donald) (Entered: 02/24/2025) |
2/24/2025 | 28 | DECLARATION of James S.S. Holtom in Support of Applicant Regeneron Pharmaceuticals, Inc.'s Ex Parte Application for an Order pursuant to 28 U.S.C. Section 1782 to take Discovery for use in Foreign Proceedings re 27 Reply to Response to Motion by Regeneron Pharmaceuticals, Inc.. (Vavala, Donald) (Entered: 02/24/2025) |
2/24/2025 | 27 | [SEALED] REPLY to Response to Motion re 1 MOTION for Issuance of Letters Rogatory filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Certificate of Service)(Vavala, Donald) (Entered: 02/24/2025) |
2/24/2025 | | SO ORDERED re 26 Unopposed MOTION to File Under Seal. ORDERED by Judge Maryellen Noreika on 2/24/2025. (dlw) (Entered: 02/24/2025) |
2/24/2025 | 26 | Unopposed MOTION to File Under Seal - filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 D. DEL. LR 7.1.1 Certification)(Vavala, Donald) (Entered: 02/24/2025) |
2/13/2025 | 25 | REDACTED VERSION of 18 Declaration by Amgen Inc.. (Egan, Brian) (Entered: 02/13/2025) |
2/13/2025 | 24 | REDACTED VERSION of 17 Declaration by Amgen Inc.. (Egan, Brian) (Entered: 02/13/2025) |
2/13/2025 | 23 | REDACTED VERSION of 16 Declaration by Amgen Inc.. (Egan, Brian) (Entered: 02/13/2025) |
2/13/2025 | 22 | REDACTED VERSION of 14 Answering Brief in Opposition by Amgen Inc.. (Egan, Brian) (Entered: 02/13/2025) |
2/11/2025 | 21 | Letter to The Honorable Maryellen Noreika from David E. Wilks regarding Response to Amgen Inc.'s February 7, 2025 filing - re 14 Answering Brief in Opposition. (Wilks, David) (Entered: 02/11/2025) |
2/10/2025 | | SO ORDERED re 13 Unopposed MOTION to Seal. ORDERED by Judge Maryellen Noreika on 2/10/2025. (dlw) (Entered: 02/10/2025) |
2/7/2025 | 20 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Amgen Inc.. (Egan, Brian) (Entered: 02/07/2025) |
2/7/2025 | 19 | DECLARATION of Abraham Vergis re 14 Answering Brief in Opposition by Amgen Inc.. (Attachments: # 1 Exhibits 1-2, # 2 Exhibits 3-7, # 3 Exhibits 9-16)(Egan, Brian) (Entered: 02/07/2025) |
2/7/2025 | 18 | [SEALED] DECLARATION of Marc Doble re 14 Answering Brief in Opposition by Amgen Inc.. (Egan, Brian) (Entered: 02/07/2025) |
2/7/2025 | 17 | [SEALED] DECLARATION of Natalia Gomez re 14 Answering Brief in Opposition by Amgen Inc.. (Egan, Brian) (Entered: 02/07/2025) |
2/7/2025 | 16 | [SEALED] DECLARATION of Angel Santiago-Lopez re 14 Answering Brief in Opposition by Amgen Inc.. (Egan, Brian) (Entered: 02/07/2025) |
2/7/2025 | 15 | DECLARATION of Brian P. Egan re 14 Answering Brief in Opposition by Amgen Inc.. (Attachments: # 1 Exhibits 1-5)(Egan, Brian) (Entered: 02/07/2025) |
2/7/2025 | 14 | [SEALED] ANSWERING BRIEF in Opposition re 1 MOTION for Issuance of Letters Rogatory filed by Amgen Inc..Reply Brief due date per Local Rules is 2/14/2025. (Egan, Brian) (Entered: 02/07/2025) |
2/7/2025 | 13 | Unopposed MOTION to Seal - filed by Amgen Inc.. (Attachments: # 1 Text of Proposed Order)(Egan, Brian) (Entered: 02/07/2025) |
1/27/2025 | 12 | Letter to The Honorable Maryellen Noreika from David E. Wilks regarding response to Amgen Inc.'s letter dated January 24, 2025 - re 11 Letter. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Wilks, David) (Entered: 01/27/2025) |
1/24/2025 | 11 | Letter to The Honorable Maryellen Noreika from Brian P. Egan regarding follow-up to January 8, 2025 - re 9 Letter. (Attachments: # 1 Exhibit A)(Egan, Brian) (Entered: 01/24/2025) |
1/24/2025 | 10 | NOTICE of Appearance of Brian P. Egan, Megan E. Dellinger, and Cameron P. Clark by Amgen Inc. (Egan, Brian) (Entered: 01/24/2025) |
1/9/2025 | | Pro Hac Vice Attorney Jonathan D. Loeb,Luke M. Reilly,Katherine A. Helm,Sharon K. Gagliardi,Charles Hsu for Regeneron Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (scs) (Entered: 01/09/2025) |
1/8/2025 | | Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) (Entered: 01/08/2025) |
1/8/2025 | 9 | Letter to The Honorable Maryellen Noreika from Brian P. Egan regarding § 1782 Application - re 1 MOTION for Issuance of Letters Rogatory. (Egan, Brian) (Entered: 01/08/2025) |
1/8/2025 | | SO ORDERED re 6 MOTION for Pro Hac Vice Appearance of Attorney Katherine A. Helm, Ph.D., 7 MOTION for Pro Hac Vice Appearance of Attorney Sharon K. Gagliardi and Luke M. Reilly, 8 MOTION for Pro Hac Vice Appearance of Attorney Jonathan Loeb, Ph.D. and Charles Hsu filed by Regeneron Pharmaceuticals, Inc. ORDERED by Judge Maryellen Noreika on 1/8/2025. (dlw) (Entered: 01/08/2025) |
1/7/2025 | 8 | MOTION for Pro Hac Vice Appearance of Attorney Jonathan Loeb, Ph.D. and Charles Hsu - filed by Regeneron Pharmaceuticals, Inc.. (Vavala, Donald) (Entered: 01/07/2025) |
1/7/2025 | 7 | MOTION for Pro Hac Vice Appearance of Attorney Sharon K. Gagliardi and Luke M. Reilly - filed by Regeneron Pharmaceuticals, Inc.. (Vavala, Donald) (Entered: 01/07/2025) |
1/7/2025 | 6 | MOTION for Pro Hac Vice Appearance of Attorney Katherine A. Helm, Ph.D. - filed by Regeneron Pharmaceuticals, Inc.. (Vavala, Donald) (Entered: 01/07/2025) |
1/7/2025 | 5 | Pro Hac Vice Fee - Credit Card Payment received for Katherine A. Helm, Ph.D, Sharon K. Gagliardi, Luke M. Reilly, Jonathan Loeb, Ph.D., and Charles Hsu. ( Payment of $ 250, receipt number ADEDC-4584503).(Vavala, Donald) (Entered: 01/07/2025) |
1/6/2025 | | No Summons Issued. (mpb) (Entered: 01/07/2025) |
1/6/2025 | 4 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Regeneron Pharmaceuticals, Inc. (mpb) (Entered: 01/07/2025) |
1/6/2025 | 3 | MEMORANDUM in Support of 1 Ex Parte Application for an Order Pursuant to 27 U.S.C. § 1782 to Take Discovery for Use in Foreign Proceedings - filed by Regeneron Pharmaceuticals, Inc. Answering Brief/Response due date per Local Rules is 1/21/2025. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D)(mpb) (Entered: 01/07/2025) |
1/6/2025 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 01/07/2025) |
1/6/2025 | 1 | Ex Parte Application for an Order Pursuant to 27 U.S.C. § 1782 to Take Discovery for Use in Foreign Proceedings (Filing fee $ 405, receipt number ADEDC-4583273) - filed by Regeneron Pharmaceuticals, Inc. (Attachments: # 1 Proposed Order, # 2 Civil Cover Sheet)(mpb) (Entered: 01/07/2025) |